| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lung Neoplasms | 41 | 2025 | 1542 | 5.560 |
Why?
|
| Smoking | 20 | 2023 | 927 | 2.620 |
Why?
|
| Genome-Wide Association Study | 23 | 2023 | 1844 | 1.950 |
Why?
|
| Genetic Predisposition to Disease | 32 | 2025 | 3416 | 1.800 |
Why?
|
| Scleroderma, Systemic | 12 | 2019 | 130 | 1.710 |
Why?
|
| Polymorphism, Single Nucleotide | 28 | 2023 | 2859 | 1.430 |
Why?
|
| Gene Expression Regulation, Neoplastic | 7 | 2025 | 2004 | 1.410 |
Why?
|
| Early Detection of Cancer | 5 | 2025 | 418 | 1.280 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 7 | 2025 | 327 | 1.140 |
Why?
|
| Gene Expression Profiling | 8 | 2026 | 1835 | 0.950 |
Why?
|
| Volatile Organic Compounds | 2 | 2021 | 13 | 0.880 |
Why?
|
| Codon, Nonsense | 3 | 2022 | 141 | 0.880 |
Why?
|
| Sequence Analysis, RNA | 1 | 2025 | 420 | 0.750 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2025 | 2122 | 0.630 |
Why?
|
| Genome, Human | 10 | 2020 | 1331 | 0.620 |
Why?
|
| Biomarkers, Tumor | 4 | 2025 | 1617 | 0.600 |
Why?
|
| Models, Biological | 3 | 2011 | 1395 | 0.600 |
Why?
|
| Breath Tests | 2 | 2021 | 182 | 0.600 |
Why?
|
| Neoplasm Proteins | 4 | 2018 | 676 | 0.600 |
Why?
|
| Genetic Variation | 6 | 2020 | 1562 | 0.600 |
Why?
|
| Tobacco Smoke Pollution | 3 | 2011 | 93 | 0.570 |
Why?
|
| DNA Repair | 3 | 2012 | 577 | 0.530 |
Why?
|
| Models, Statistical | 7 | 2019 | 493 | 0.500 |
Why?
|
| Humans | 80 | 2026 | 131788 | 0.500 |
Why?
|
| Case-Control Studies | 19 | 2020 | 3451 | 0.490 |
Why?
|
| Genomic Imprinting | 3 | 2007 | 127 | 0.490 |
Why?
|
| Quantitative Trait Loci | 6 | 2022 | 307 | 0.490 |
Why?
|
| Mutation, Missense | 10 | 2024 | 932 | 0.470 |
Why?
|
| Neoplasms | 8 | 2020 | 2963 | 0.460 |
Why?
|
| Diet | 2 | 2013 | 1119 | 0.450 |
Why?
|
| Models, Genetic | 4 | 2008 | 752 | 0.420 |
Why?
|
| Risk Factors | 24 | 2026 | 10965 | 0.420 |
Why?
|
| Genetic Linkage | 4 | 2007 | 472 | 0.420 |
Why?
|
| Carcinogenesis | 1 | 2017 | 357 | 0.420 |
Why?
|
| Gene Frequency | 7 | 2022 | 750 | 0.420 |
Why?
|
| Multivariate Analysis | 4 | 2022 | 1406 | 0.400 |
Why?
|
| Male | 43 | 2026 | 65292 | 0.400 |
Why?
|
| Alleles | 6 | 2020 | 1711 | 0.400 |
Why?
|
| Sex Factors | 4 | 2011 | 1347 | 0.390 |
Why?
|
| Betaine | 1 | 2013 | 19 | 0.390 |
Why?
|
| Introns | 1 | 2014 | 288 | 0.390 |
Why?
|
| Choline | 1 | 2013 | 51 | 0.380 |
Why?
|
| Neoplasm Staging | 4 | 2025 | 1322 | 0.380 |
Why?
|
| Middle Aged | 29 | 2026 | 28897 | 0.380 |
Why?
|
| Selection, Genetic | 3 | 2024 | 157 | 0.380 |
Why?
|
| Female | 39 | 2026 | 71222 | 0.360 |
Why?
|
| Models, Theoretical | 1 | 2014 | 366 | 0.360 |
Why?
|
| Computer Simulation | 6 | 2025 | 684 | 0.350 |
Why?
|
| Logistic Models | 8 | 2022 | 1838 | 0.340 |
Why?
|
| Odds Ratio | 6 | 2022 | 1235 | 0.340 |
Why?
|
| Evolution, Molecular | 1 | 2014 | 657 | 0.330 |
Why?
|
| Receptors, Nicotinic | 1 | 2011 | 132 | 0.330 |
Why?
|
| Aged | 21 | 2020 | 21263 | 0.320 |
Why?
|
| SEER Program | 2 | 2025 | 210 | 0.300 |
Why?
|
| Genetic Loci | 4 | 2016 | 359 | 0.290 |
Why?
|
| Biological Evolution | 4 | 2015 | 230 | 0.280 |
Why?
|
| Prostatic Neoplasms | 5 | 2017 | 1419 | 0.270 |
Why?
|
| Body Size | 1 | 2007 | 59 | 0.260 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2007 | 77 | 0.260 |
Why?
|
| Research Design | 1 | 2011 | 723 | 0.250 |
Why?
|
| Genes, Neoplasm | 2 | 2019 | 80 | 0.230 |
Why?
|
| Feeding Behavior | 1 | 2011 | 724 | 0.230 |
Why?
|
| Penetrance | 1 | 2025 | 117 | 0.230 |
Why?
|
| Data Interpretation, Statistical | 2 | 2005 | 227 | 0.220 |
Why?
|
| Melanoma | 2 | 2023 | 921 | 0.220 |
Why?
|
| Oncogenes | 2 | 2022 | 164 | 0.210 |
Why?
|
| Skin Neoplasms | 2 | 2023 | 904 | 0.210 |
Why?
|
| Family | 1 | 2007 | 593 | 0.210 |
Why?
|
| Genetic Association Studies | 2 | 2022 | 838 | 0.200 |
Why?
|
| Receptors, Interleukin-12 | 2 | 2014 | 13 | 0.200 |
Why?
|
| Survival Analysis | 2 | 2025 | 1522 | 0.200 |
Why?
|
| Neoplasm Metastasis | 2 | 2025 | 711 | 0.200 |
Why?
|
| Interferon Regulatory Factors | 2 | 2014 | 46 | 0.200 |
Why?
|
| Mutation | 4 | 2024 | 6194 | 0.190 |
Why?
|
| RNA Splicing | 3 | 2014 | 235 | 0.190 |
Why?
|
| Adult | 16 | 2026 | 31710 | 0.180 |
Why?
|
| Software | 1 | 2007 | 752 | 0.180 |
Why?
|
| Nucleotides | 1 | 2022 | 90 | 0.180 |
Why?
|
| Cohort Studies | 8 | 2023 | 5122 | 0.180 |
Why?
|
| Exons | 3 | 2014 | 769 | 0.170 |
Why?
|
| Venous Thrombosis | 1 | 2023 | 168 | 0.170 |
Why?
|
| Germ-Line Mutation | 2 | 2020 | 373 | 0.170 |
Why?
|
| Conserved Sequence | 1 | 2022 | 282 | 0.170 |
Why?
|
| Prognosis | 5 | 2023 | 4953 | 0.170 |
Why?
|
| Frameshift Mutation | 2 | 2019 | 202 | 0.170 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2026 | 404 | 0.170 |
Why?
|
| Tumor Burden | 2 | 2012 | 239 | 0.170 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2014 | 226 | 0.170 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2024 | 759 | 0.170 |
Why?
|
| Aged, 80 and over | 9 | 2020 | 6916 | 0.160 |
Why?
|
| Venous Thromboembolism | 1 | 2023 | 179 | 0.160 |
Why?
|
| Reproducibility of Results | 4 | 2022 | 2993 | 0.160 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2020 | 100 | 0.160 |
Why?
|
| Glioblastoma | 1 | 2023 | 346 | 0.150 |
Why?
|
| Genotype | 8 | 2018 | 2655 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2019 | 109 | 0.140 |
Why?
|
| Obesity | 2 | 2007 | 2390 | 0.140 |
Why?
|
| Telomerase | 1 | 2019 | 157 | 0.140 |
Why?
|
| Age Factors | 4 | 2011 | 2872 | 0.140 |
Why?
|
| Octanes | 1 | 2017 | 1 | 0.140 |
Why?
|
| DNA-Binding Proteins | 5 | 2022 | 1964 | 0.140 |
Why?
|
| Body Mass Index | 2 | 2005 | 1695 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2018 | 144 | 0.140 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2017 | 66 | 0.130 |
Why?
|
| Furans | 1 | 2017 | 31 | 0.130 |
Why?
|
| G1 Phase Cell Cycle Checkpoints | 1 | 2017 | 16 | 0.130 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2020 | 1008 | 0.130 |
Why?
|
| Computational Biology | 3 | 2015 | 872 | 0.130 |
Why?
|
| Risk | 3 | 2020 | 739 | 0.130 |
Why?
|
| Idiopathic Interstitial Pneumonias | 1 | 2016 | 9 | 0.120 |
Why?
|
| Genomics | 3 | 2014 | 1626 | 0.120 |
Why?
|
| Rhinitis, Allergic, Seasonal | 2 | 2006 | 21 | 0.120 |
Why?
|
| CpG Islands | 4 | 2023 | 339 | 0.120 |
Why?
|
| Surveys and Questionnaires | 4 | 2020 | 4053 | 0.120 |
Why?
|
| Breast Neoplasms | 2 | 2019 | 2650 | 0.120 |
Why?
|
| Age of Onset | 3 | 2012 | 631 | 0.120 |
Why?
|
| Blood | 1 | 2015 | 100 | 0.110 |
Why?
|
| Pedigree | 3 | 2020 | 1712 | 0.110 |
Why?
|
| Adenocarcinoma | 2 | 2020 | 999 | 0.110 |
Why?
|
| beta Karyopherins | 1 | 2014 | 16 | 0.110 |
Why?
|
| Linkage Disequilibrium | 2 | 2014 | 318 | 0.110 |
Why?
|
| Genes, p53 | 2 | 2005 | 213 | 0.110 |
Why?
|
| Colonic Neoplasms | 1 | 2017 | 265 | 0.110 |
Why?
|
| Disease Progression | 2 | 2026 | 2221 | 0.110 |
Why?
|
| Likelihood Functions | 2 | 2005 | 117 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2014 | 87 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2014 | 91 | 0.100 |
Why?
|
| HLA Antigens | 2 | 2014 | 230 | 0.100 |
Why?
|
| rhoB GTP-Binding Protein | 1 | 2012 | 1 | 0.100 |
Why?
|
| Europe | 4 | 2019 | 373 | 0.100 |
Why?
|
| Lung | 2 | 2023 | 1566 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 16 | 2 | 2003 | 150 | 0.090 |
Why?
|
| Environmental Exposure | 1 | 2015 | 291 | 0.090 |
Why?
|
| Cocarcinogenesis | 1 | 2011 | 15 | 0.090 |
Why?
|
| Food, Organic | 1 | 2011 | 2 | 0.090 |
Why?
|
| Genetic Markers | 2 | 2011 | 605 | 0.090 |
Why?
|
| Selection Bias | 1 | 2011 | 16 | 0.090 |
Why?
|
| Autoantibodies | 2 | 2011 | 466 | 0.090 |
Why?
|
| Diet, Fat-Restricted | 1 | 2011 | 37 | 0.090 |
Why?
|
| Membrane Proteins | 1 | 2019 | 1610 | 0.090 |
Why?
|
| Exhalation | 1 | 2021 | 16 | 0.090 |
Why?
|
| Eligibility Determination | 1 | 2011 | 36 | 0.090 |
Why?
|
| Vitamin A | 1 | 2011 | 57 | 0.080 |
Why?
|
| Registries | 3 | 2012 | 1598 | 0.080 |
Why?
|
| Carotenoids | 1 | 2011 | 80 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2013 | 589 | 0.080 |
Why?
|
| Phenotype | 5 | 2012 | 4528 | 0.080 |
Why?
|
| CD3 Complex | 1 | 2010 | 93 | 0.080 |
Why?
|
| Fruit | 1 | 2011 | 234 | 0.080 |
Why?
|
| Forecasting | 1 | 2011 | 361 | 0.080 |
Why?
|
| Genotyping Techniques | 2 | 2020 | 110 | 0.080 |
Why?
|
| Interviews as Topic | 1 | 2011 | 441 | 0.080 |
Why?
|
| Disease | 1 | 2010 | 125 | 0.070 |
Why?
|
| Databases, Nucleic Acid | 2 | 2008 | 73 | 0.070 |
Why?
|
| DNA Mutational Analysis | 1 | 2011 | 803 | 0.070 |
Why?
|
| Texas | 3 | 2013 | 3622 | 0.070 |
Why?
|
| Vegetables | 1 | 2011 | 271 | 0.070 |
Why?
|
| Nuclear Proteins | 2 | 2013 | 1226 | 0.070 |
Why?
|
| Energy Intake | 1 | 2011 | 501 | 0.070 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 1078 | 0.070 |
Why?
|
| Motor Activity | 1 | 2011 | 507 | 0.070 |
Why?
|
| Confidence Intervals | 1 | 2008 | 272 | 0.070 |
Why?
|
| DNA Breaks | 1 | 2007 | 25 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2008 | 432 | 0.070 |
Why?
|
| Mutagens | 1 | 2007 | 48 | 0.070 |
Why?
|
| Asthma | 2 | 2006 | 926 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 1130 | 0.060 |
Why?
|
| Organ Specificity | 2 | 2019 | 400 | 0.060 |
Why?
|
| Proteins | 1 | 2012 | 1027 | 0.060 |
Why?
|
| DNA Methylation | 2 | 2023 | 1088 | 0.060 |
Why?
|
| Age Distribution | 1 | 2007 | 429 | 0.060 |
Why?
|
| Dust | 1 | 2006 | 31 | 0.060 |
Why?
|
| Epidemiologic Studies | 1 | 2006 | 41 | 0.060 |
Why?
|
| Genetics, Population | 2 | 2008 | 185 | 0.060 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2014 | 600 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 2 | 2023 | 1219 | 0.060 |
Why?
|
| Regression Analysis | 1 | 2007 | 773 | 0.060 |
Why?
|
| Cell Growth Processes | 1 | 2005 | 62 | 0.060 |
Why?
|
| Gene Expression Regulation | 2 | 2026 | 2353 | 0.060 |
Why?
|
| Radiography, Thoracic | 1 | 2005 | 147 | 0.050 |
Why?
|
| Inflammation | 1 | 2011 | 1493 | 0.050 |
Why?
|
| Regulatory Sequences, Ribonucleic Acid | 1 | 2003 | 14 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2003 | 32 | 0.050 |
Why?
|
| Lung Diseases | 1 | 2007 | 401 | 0.050 |
Why?
|
| Body Constitution | 1 | 2002 | 42 | 0.050 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2004 | 274 | 0.050 |
Why?
|
| Minisatellite Repeats | 1 | 2002 | 45 | 0.050 |
Why?
|
| Predictive Value of Tests | 2 | 2012 | 2299 | 0.050 |
Why?
|
| Sample Size | 1 | 2002 | 86 | 0.050 |
Why?
|
| Monte Carlo Method | 1 | 2003 | 103 | 0.050 |
Why?
|
| Constriction, Pathologic | 1 | 2023 | 228 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2002 | 119 | 0.050 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2002 | 106 | 0.050 |
Why?
|
| Risk Assessment | 2 | 2009 | 3696 | 0.050 |
Why?
|
| Early Diagnosis | 1 | 2003 | 192 | 0.050 |
Why?
|
| Haplotypes | 2 | 2014 | 550 | 0.040 |
Why?
|
| Siblings | 1 | 2002 | 204 | 0.040 |
Why?
|
| Multifactorial Inheritance | 1 | 2002 | 173 | 0.040 |
Why?
|
| Silent Mutation | 1 | 2020 | 3 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2002 | 364 | 0.040 |
Why?
|
| Chromosome Aberrations | 1 | 2023 | 577 | 0.040 |
Why?
|
| Jews | 1 | 2020 | 33 | 0.040 |
Why?
|
| Open Reading Frames | 2 | 2014 | 200 | 0.040 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2019 | 30 | 0.040 |
Why?
|
| Ultraviolet Rays | 1 | 2020 | 195 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2023 | 503 | 0.040 |
Why?
|
| Biomarkers | 2 | 2023 | 3411 | 0.040 |
Why?
|
| Mucins | 1 | 2019 | 69 | 0.040 |
Why?
|
| Algorithms | 3 | 2012 | 1685 | 0.040 |
Why?
|
| Mutation Rate | 1 | 2018 | 68 | 0.040 |
Why?
|
| Gene Ontology | 1 | 2018 | 54 | 0.040 |
Why?
|
| Child | 3 | 2018 | 26317 | 0.040 |
Why?
|
| Liver | 1 | 2026 | 1799 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2022 | 548 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2023 | 766 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 698 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2009 | 6509 | 0.030 |
Why?
|
| Loss of Function Mutation | 1 | 2019 | 160 | 0.030 |
Why?
|
| Heterozygote | 1 | 2020 | 728 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2020 | 500 | 0.030 |
Why?
|
| Gene-Environment Interaction | 1 | 2018 | 128 | 0.030 |
Why?
|
| Linear Models | 1 | 2019 | 695 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2018 | 384 | 0.030 |
Why?
|
| Mass Screening | 2 | 2012 | 825 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2011 | 12997 | 0.030 |
Why?
|
| Young Adult | 2 | 2020 | 10102 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2018 | 15057 | 0.030 |
Why?
|
| Carrier Proteins | 2 | 2014 | 1024 | 0.030 |
Why?
|
| Interleukin-12 Subunit p35 | 1 | 2014 | 6 | 0.030 |
Why?
|
| Microchip Analytical Procedures | 1 | 2014 | 4 | 0.030 |
Why?
|
| Autophagy-Related Protein 5 | 1 | 2014 | 12 | 0.030 |
Why?
|
| Endodeoxyribonucleases | 1 | 2014 | 49 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2012 | 17667 | 0.030 |
Why?
|
| Severity of Illness Index | 2 | 2012 | 3094 | 0.020 |
Why?
|
| Co-Repressor Proteins | 1 | 2013 | 38 | 0.020 |
Why?
|
| Bayes Theorem | 1 | 2014 | 306 | 0.020 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2014 | 162 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2014 | 251 | 0.020 |
Why?
|
| Adolescent | 2 | 2018 | 20994 | 0.020 |
Why?
|
| Life Style | 1 | 2015 | 444 | 0.020 |
Why?
|
| Calibration | 1 | 2012 | 95 | 0.020 |
Why?
|
| Vital Capacity | 1 | 2012 | 88 | 0.020 |
Why?
|
| United States | 3 | 2012 | 11815 | 0.020 |
Why?
|
| Autoimmune Diseases | 1 | 2014 | 275 | 0.020 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2011 | 22 | 0.020 |
Why?
|
| Airway Remodeling | 1 | 2011 | 22 | 0.020 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2011 | 33 | 0.020 |
Why?
|
| Activin Receptors, Type I | 1 | 2011 | 34 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2012 | 321 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2013 | 432 | 0.020 |
Why?
|
| Mortality | 1 | 2012 | 261 | 0.020 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2012 | 176 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2002 | 2082 | 0.020 |
Why?
|
| Genes, Overlapping | 1 | 2008 | 7 | 0.020 |
Why?
|
| 5' Untranslated Regions | 1 | 2008 | 57 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2008 | 164 | 0.020 |
Why?
|
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 1 | 2007 | 10 | 0.020 |
Why?
|
| Bleomycin | 1 | 2007 | 111 | 0.020 |
Why?
|
| Comorbidity | 1 | 2012 | 1600 | 0.020 |
Why?
|
| Survival Rate | 1 | 2012 | 2151 | 0.020 |
Why?
|
| Family Health | 1 | 2007 | 251 | 0.020 |
Why?
|
| Bone Neoplasms | 1 | 2010 | 441 | 0.010 |
Why?
|
| Mice | 1 | 2023 | 18482 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2018 | 8597 | 0.010 |
Why?
|
| Lod Score | 1 | 2005 | 128 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2005 | 47 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2005 | 68 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2005 | 92 | 0.010 |
Why?
|
| Incidence | 1 | 2012 | 3349 | 0.010 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2003 | 39 | 0.010 |
Why?
|
| MutL Protein Homolog 1 | 1 | 2003 | 52 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2008 | 1398 | 0.010 |
Why?
|
| Infant | 1 | 2018 | 13324 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 5297 | 0.010 |
Why?
|
| Animals | 1 | 2023 | 34405 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2005 | 495 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2003 | 632 | 0.010 |
Why?
|